.png){kind=icon}
-
Commercialization
市场访问和第IV阶段解决方案
-
Data & Technology Solutions
Data Capabilities 设计更美好的研究 Improve Study Recruitment 减少研究风险 Gain Operational Insights Ensure Data Quality Access Central Laboratory Information 授权您的数据 Maximize Product Access Transform Patient SafetyClinical Trials
Clinical Pharmacology Early Clinical 晚期临床 第四阶段& RWE 数据分析与报告 Global Compliance CRU Virtual Tours 分散和虚拟化 PoC研究
-
Call Us
The Americas
+ 1.888.COVANCE（+1.888.268.2623） 1.609.452.4440Europe/Africa
+00.800.2682.2682 +44.1423.500888Asia/Pacific
+800.6568.3000 +65.6.5686588Global Office Locations
yaboapp体育官网
FaDu: Human Pharyngeal Squamous Cell Carcinoma
(The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact Covance.)
***请注意，小区线不销售，不可用的购物。***
Fill out our tumor models contact form to get started setting up your next preclinical study with us.
组型：头部和颈部[鳞状细胞癌]
肿瘤线：Human
REF#790.
Copyright © 2020 Covance Inc. All rights reserved.
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.